Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway

Osteosarcoma is the most common cause of cancer-associated mortality and the prognosis is yet to be fully elucidated due to the paucity of effective therapeutic targets that significantly influence the quality of life and mean survival rates of patients with osteosarcoma. Studies have showed that tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi-Jiong, Zhang, Guo-Ping, Zhao, Feng, Li, Rui-Qi, Liu, Shao-Jun, Zhao, Zeng-Ren, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792772/
https://www.ncbi.nlm.nih.gov/pubmed/29467844
http://dx.doi.org/10.3892/etm.2017.5679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792772/
https://www.ncbi.nlm.nih.gov/pubmed/29467844
http://dx.doi.org/10.3892/etm.2017.5679

Ejemplares similares